BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22495562)

  • 41. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Typing of Thai clinical isolates of Mycobacterium leprae and analysis of leprosy transmission by polymorphism of tandem repeats.
    Srisungngam S; Rudeeaneksin J; Wattanpokayakit S; Pasadorn S; Tragoolpua R; Suwanrit S; Sawanpanyalert P; Phetsuksiri B
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):714-20. PubMed ID: 17883012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries.
    Matsuoka M; Aye KS; Kyaw K; Tan EV; Balagon MV; Saunderson P; Gelber R; Makino M; Nakajima C; Suzuki Y
    J Med Microbiol; 2008 Oct; 57(Pt 10):1213-1219. PubMed ID: 18809547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrapatient comparison of Mycobacterium leprae by VNTR analysis in nasal secretions and skin biopsy in a Brazilian leprosy endemic region.
    Lima LNGC; Fontes ANB; Li W; Suffys PN; Vissa VD; Mota RMS; Almeida RLF; Pontes MA; Gonçales HS; Frota CC; Rodrigues LC; Kendall C; Kerr LRFS
    Lepr Rev; 2016 Dec; 87(4):486-500. PubMed ID: 30226353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
    Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
    Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India.
    Lavania M; Nigam A; Turankar RP; Singh I; Gupta P; Kumar S; Sengupta U; John AS
    Clin Microbiol Infect; 2015 Dec; 21(12):e85-6. PubMed ID: 26314915
    [No Abstract]   [Full Text] [Related]  

  • 48. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
    Matsuoka M; Suzuki Y; Makino M
    Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristic mutations found in the ML0411 gene of Mycobacterium leprae isolated in Northeast Asian countries.
    Kai M; Nakata N; Matsuoka M; Sekizuka T; Kuroda M; Makino M
    Infect Genet Evol; 2013 Oct; 19():200-4. PubMed ID: 23892035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
    Zhang L; Namisato M; Matsuoka M
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report: Multidrug-Resistant
    Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
    Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep.
    Jouet A; Braet SM; Gaudin C; Bisch G; Vasconcellos S; Epaminondas Nicacio de Oliveira do Livramento RE; Prado Palacios YY; Fontes AB; Lucena N; Rosa P; Moraes M; La K; Badalato N; Lenoir E; Ferré A; Clément M; Hasker E; Grillone SH; Abdou W; Said A; Assoumani Y; Attoumani N; Laurent Y; Cambau E; de Jong BC; Suffys PN; Supply P
    EBioMedicine; 2023 Jul; 93():104649. PubMed ID: 37327675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transmission of Drug-Resistant Leprosy in Guinea-Conakry Detected Using Molecular Epidemiological Approaches.
    Avanzi C; Busso P; Benjak A; Loiseau C; Fomba A; Doumbia G; Camara I; Lamou A; Sock G; Drame T; Kodio M; Sakho F; Sow SO; Cole ST; Johnson RC
    Clin Infect Dis; 2016 Dec; 63(11):1482-1484. PubMed ID: 27558568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
    Sapkota BR; Ranjit C; Macdonald M
    Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy.
    Martinez AN; Britto CF; Nery JA; Sampaio EP; Jardim MR; Sarno EN; Moraes MO
    J Clin Microbiol; 2006 Sep; 44(9):3154-9. PubMed ID: 16954241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SNP genotypes of Mycobacterium leprae isolates in Thailand and their combination with rpoT and TTC genotyping for analysis of leprosy distribution and transmission.
    Phetsuksiri B; Srisungngam S; Rudeeaneksin J; Bunchoo S; Lukebua A; Wongtrungkapun R; Paitoon S; Sakamuri RM; Brennan PJ; Vissa V
    Jpn J Infect Dis; 2012; 65(1):52-6. PubMed ID: 22274158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single nucleotide polymorphism-based molecular typing of M. leprae from multicase families of leprosy patients and their surroundings to understand the transmission of leprosy.
    Turankar RP; Lavania M; Chaitanya VS; Sengupta U; Darlong J; Darlong F; Siva Sai KS; Jadhav RS
    Clin Microbiol Infect; 2014 Mar; 20(3):O142-9. PubMed ID: 24520878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?
    Narang T; Kamat D; Thakur V; Lavania M; Singh I; Ahuja M; Dogra S
    Clin Exp Dermatol; 2022 Feb; 47(2):297-302. PubMed ID: 34382256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.